Cargando…

Precision medicine and personalising therapy in pulmonary hypertension: seeing the light from the dawn of a new era

Pulmonary hypertension (PH) and pulmonary arterial hypertension (PAH) include different cardiopulmonary disorders in which the interaction of multiple genes with environmental and behavioural factors modulates the onset and the progression of these severe conditions. Although the development of ther...

Descripción completa

Detalles Bibliográficos
Autores principales:	Savale, Laurent, Guignabert, Christophe, Weatherald, Jason, Humbert, Marc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2018
Materias:	Series
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488842/ https://www.ncbi.nlm.nih.gov/pubmed/29653948 http://dx.doi.org/10.1183/16000617.0004-2018

Ejemplares similares

Acute decompensated pulmonary hypertension
por: Savale, Laurent, et al.
Publicado: (2017)

Sex and gender in pulmonary arterial hypertension
por: Cheron, Céline, et al.
Publicado: (2021)

Screening for pulmonary arterial hypertension in systemic sclerosis
por: Weatherald, Jason, et al.
Publicado: (2019)

Pulmonary hypertension associated with neurofibromatosis type 1
por: Jutant, Etienne-Marie, et al.
Publicado: (2018)

Exertional dyspnoea in pulmonary arterial hypertension
por: Dumitrescu, Daniel, et al.
Publicado: (2017)

Pulmonary Vascular Resistance in Pulmonary Arterial Hypertension: La Pièce de Résistance?
por: Weatherald, Jason, et al.
Publicado: (2021)

Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives
por: Humbert, Marc, et al.
Publicado: (2019)

Pulmonary capillary haemangiomatosis: a distinct entity?
por: Weatherald, Jason, et al.
Publicado: (2020)

Personalised pulmonary rehabilitation in COPD
por: Wouters, Emiel F.M., et al.
Publicado: (2018)

Personalised medicine for nonsmall cell lung cancer
por: Mascaux, Céline, et al.
Publicado: (2017)

Seeing the Forest for the (Arterial) Tree: Vascular Pruning and the Chronic Obstructive Pulmonary Disease Pulmonary Vascular Phenotype
por: Weatherald, Jason, et al.
Publicado: (2019)

Ventilatory efficiency in pulmonary vascular diseases
por: Weatherald, Jason, et al.
Publicado: (2021)

Intensive care, right ventricular support and lung transplantation in patients with pulmonary hypertension
por: Hoeper, Marius M., et al.
Publicado: (2019)

The isobaric pulmonary arterial compliance in pulmonary hypertension
por: Chemla, Denis, et al.
Publicado: (2021)

Illuminating the Importance of Pulmonary Arterial Compliance in Pulmonary Hypertension
por: Weatherald, Jason, et al.
Publicado: (2023)

Oropharyngeal cancer: the dawn of the RNA era in precision medicine
por: Rampias, Theodoros
Publicado: (2020)

Personalised medicine in asthma: time for action: Number 1 in the Series “Personalised medicine in respiratory diseases” Edited by Renaud Louis and Nicolas Roche
por: Chung, Kian Fan
Publicado: (2017)

Personalised medicine in interstitial lung diseases: Number 6 in the Series “Personalised medicine in respiratory diseases” Edited by Renaud Louis and Nicolas Roche
por: Kokosi, Maria A., et al.
Publicado: (2018)

Heritable pulmonary hypertension: from bench to bedside
por: Girerd, Barbara, et al.
Publicado: (2017)

Pulmonary arterial hypertension registries: past, present and into the future
por: Weatherald, Jason, et al.
Publicado: (2019)

Personalised medicine in sleep respiratory disorders: focus on obstructive sleep apnoea diagnosis and treatment
por: Bonsignore, Maria R., et al.
Publicado: (2017)

Reply to Jin et al. and to Sun et al.
por: Boucly, Athénaïs, et al.
Publicado: (2021)

Mechanisms, measurement and management of exertional dyspnoea in asthma: Number 5 in the Series “Exertional dyspnoea” Edited by Pierantonio Laveneziana and Piergiuseppe Agostoni
por: Weatherald, Jason, et al.
Publicado: (2017)

[Formula: see text] in the Standard Model at the Dawn of the 2020s
por: Aebischer, Jason, et al.
Publicado: (2020)

Dawn of Precision Medicine in Psoriatic Arthritis
por: Miyagawa, Ippei, et al.
Publicado: (2022)

DAWN OF PRECISION IN PSYCHIATRY
por: Sethi, B. B.
Publicado: (1981)

Endothelial cell dysfunction: a major player in SARS-CoV-2 infection (COVID-19)?
por: Huertas, Alice, et al.
Publicado: (2020)

Dendritic Cells in Pulmonary Hypertension: Foot Soldiers or Hidden Enemies?
por: Guignabert, Christophe
Publicado: (2020)

Diagnosis of pulmonary hypertension
por: Frost, Adaani, et al.
Publicado: (2019)

Tumoral pulmonary hypertension
por: Price, Laura C., et al.
Publicado: (2019)

Pharmacogenomics in the era of personalised medicine
por: White, Cassandra, et al.
Publicado: (2022)

Screening for pulmonary arterial hypertension in adults carrying a BMPR2 mutation
por: Montani, David, et al.
Publicado: (2021)

ERAS – The dawn of a new era!
por: Gopinath, Ramachandran, et al.
Publicado: (2019)

Clinical phenotypes and survival of pre-capillary pulmonary hypertension in systemic sclerosis
por: Launay, David, et al.
Publicado: (2018)

Pulmonary arterial hypertension populations of special interest: portopulmonary hypertension and pulmonary arterial hypertension associated with congenital heart disease
por: Savale, Laurent, et al.
Publicado: (2019)

Chronic thromboembolic pulmonary hypertension
por: Kim, Nick H., et al.
Publicado: (2019)

New trends in pulmonary hypertension
por: Cullivan, Sarah, et al.
Publicado: (2023)

The dawn of a new era
Publicado: (2017)

The Dawn of the Post-Naturalness Era
por: Giudice, Gian Francesco
Publicado: (2019)

Pulmonary hypertension associated with busulfan
por: Hagenburg, Jean, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_feg1nnmvpsv866hvkf385mdvgt